BIM
REGN icon

BlackRock Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

BlackRock Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$124M Sell
339,110
-242,010
-42% -$92M 0.14% 140
2016
Q3 		$234M Buy
581,120
+177,702
+44% +$71.3M 0.29% 70
2016
Q2 		$141M Buy
403,418
+232,471
+136% +$89.5M 0.18% 119
2016
Q1 		$61.6M Sell
170,947
-7,274
-4% -$3M 0.08% 242
2015
Q4 		$96.8M Buy
178,221
+1,306
+0.7% +$708K 0.12% 165
2015
Q3 		$82.3M Sell
176,915
-2,589
-1% -$1.39M 0.11% 187
2015
Q2 		$91.6M Sell
179,504
-132,096
-42% -$64.5M 0.11% 182
2015
Q1 		$141M Sell
311,600
-101,984
-25% -$43.2M 0.18% 118
2014
Q4 		$170M Sell
413,584
-126,401
-23% -$49.7M 0.22% 103
2014
Q3 		$195M Sell
539,985
-97,924
-15% -$32.8M 0.27% 80
2014
Q2 		$180M Buy
637,909
+248,105
+64% +$73.5M 0.24% 87
2014
Q1 		$117M Sell
389,804
-44,767
-10% -$13.8M 0.17% 125
2013
Q4 		$120M Buy
434,571
+188,548
+77% +$54.2M 0.18% 118
2013
Q3 		$77M Buy
246,023
+113,514
+86% +$29.9M 0.13% 160
2013
Q2 		$29.8M Buy
+132,509
New +$30.9M 0.05% 325

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock Investment Management's REGN Position: Q4 2016 in Review

BlackRock Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 42% in Q4 2016, selling an estimated $92M and leaving 339,110 shares worth $124M. The position accounts for 0.14% of the portfolio, ranked #140.

BlackRock Investment Management first reported a position in REGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $234M in Q3 2016. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2016.

  • BlackRock Investment Management held 339,110 shares of Regeneron Pharmaceuticals worth $124M as of Q4 2016.
  • BlackRock Investment Management sold 242,010 Regeneron Pharmaceuticals shares in Q4 2016, an estimated $92M.
  • Regeneron Pharmaceuticals made up 0.14% of BlackRock Investment Management's portfolio in Q4 2016, its #140 holding.
  • BlackRock Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Regeneron Pharmaceuticals position peaked at $234M in Q3 2016.
  • 576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.